Cocer Peptides ye ŋlɔe 
ŋkeke 29 enye sia.
Lãmetsiŋusẽa ɖɔa sidzedze, seselelãme, kple ŋutilã ƒe dɔwɔwɔ ɖo to ahɔhɔ̃mekawo ƒe kadodo sesẽwo kple lãmenugbagbeviwo ƒe dzesimɔwo dzi. Nusiwo gblẽ alo gbegblẽ le ɖoɖo sia me ate ŋu ahe lãmesẽkuxi gãwo abe Alzheimer ƒe dɔléle, Parkinson ƒe dɔléle, dzimaɖitsitsi, blanuiléle, kple ahɔhɔ̃mekawo ƒe ʋuʋu ene vɛ. Mɔ vevi siwo dzi woato alé ahɔhɔ̃mekawo kple susu ƒe lãmesẽ me ɖe asi—siwo dometɔ aɖewoe nye ahɔhɔ̃mekawo takpɔkpɔ, susu ƒe dɔwɔwɔ nyuie, seselelãme ƒe ɖoɖowɔwɔ, kple ahɔhɔ̃mekawo ƒe abi ɖɔɖɔɖo—nɔ te ɖe nudede ahɔhɔ̃mekawo ƒe agbetsitsi, lãmenugbagbeviwo ƒe ʋuʋu, ahɔhɔ̃mekawo ƒe dɔdzẽ, kple gbugbɔgadzɔ ƒe mɔnuwo me pɛpɛpɛ dzi. Peptide-nu siwo ƒe dɔlékuiwo ƒe dɔwɔwɔ sɔ gbɔ eye ʋu kple ahɔhɔ̃ ƒe mɔxenu te ŋu gena ɖe lãme na ame la do abe molecule nyuiwo ene hena ahɔhɔ̃mekawo ƒe mɔwo dzi dzedze. Wohea ahɔhɔ̃mekawo ƒe dɔmawɔmawɔ nyuie ɖe megbe le lãmenugbagbeviwo ƒe ɖoɖo nu eye wodoa dɔwɔwɔ ƒe ɖɔɖɔɖo ɖe ŋgɔ, si ʋua mɔfiame yeyewo ɖi na mɔxexe ɖe ahɔhɔ̃mekawo ƒe dɔlélewo nu kple wo dada.
Figure 1 Dɔlékuiwutikewo ƒe mɔnu siwo wodo ɖa le dɔwɔwɔ ƒe susu ƒe dɔmawɔmawɔ nyuie me. Dzɔtsoƒe: Dɔwɔna ƒe susu ƒe dɔléle: Beyond pseudodementia (2024).
Mɔnuwo Kple Dɔnɔdzikpɔƒe ƒe Asixɔxɔ si le Nuto Vevi Siwo Wozãna Ŋu
1. Ahɔhɔ̃mekawo Takpɔkpɔ: Takpɔkpɔ le Akpa Vovovowo me Tsi Ahɔhɔ̃mekawo ƒe Nugbegblẽ le Nu Ŋu
Peptide-nu siwo nye ametakpɔnu na lãmekawo to antioxidation, anti-inflammation, kple mitochondrial takpɔkpɔ me.
Oxidative stress ƒe nugbegblẽ dzi ɖeɖe kpɔtɔ
Peptide siwo woɖo ɖe mitochondria ŋu (le kpɔɖeŋu me, SS-31) gena ɖe mitochondria ƒe lãkusi ememetɔ me, si xea mɔ na oxygen ƒomevi siwo wɔa dɔ fũu akpa (ROS) ƒe wɔwɔ. Esia kpɔa mitochondrial DNA kple membrane ƒe blibonyenye ta, si hea ahɔhɔ̃mekawo ƒe apoptosis ɖe megbe. Le ʋusɔgbɔdɔ kple Parkinson ƒe dɔléle ƒe kpɔɖeŋuwo me la, peptide siawo ɖea dopaminergic neuron ƒe bu dzi kpɔtɔna ŋutɔ.
Mɔxexe ɖe ahɔhɔ̃mekawo ƒe dɔdzẽ ƒe tsidzadzawo nu
Peptide aɖewo (le kpɔɖeŋu me, Cerebrolysin), abe neuropeptide complexes ene, ɖea NF-κB ƒe dɔdzẽmɔa dzi kpɔtɔna. Woɖea microglial ƒe dɔwɔwɔ fũ akpa kple β-amyloid (Aβ)-si hea dɔdzẽ ƒe ŋuɖoɖowo dzi kpɔtɔna esime wodoa ahɔhɔ̃mekawo ƒe dɔwɔwɔ (BDNF, NGF) ƒe ɖeɖefia ɖe ŋgɔ, eye woléa nuto sue si nyo na ahɔhɔ̃mekawo ƒe agbetsitsi ɖe te.
Ʋu kple ahɔhɔ̃ ƒe mɔxenu takpɔkpɔ
Peptides abe TB 500 ene doa ŋusẽ protein siwo ƒoa ƒu sesĩe ƒe ɖeɖefia le ʋukawo me lãmenugbagbeviwo me, si wɔnɛ be nusiwo gblẽa nu le ame ŋu ƒe gege ɖe lãme na ame dzi kpɔtɔna. Esia ɖea ahɔhɔ̃mekawo ƒe ʋuʋu kple ahɔhɔ̃mekawo ƒe kuku ƒe afɔkua dzi kpɔtɔna vevietɔ le ahɔhɔ̃mekawo ƒe abixɔxɔ sesẽ me.
2. Sidzedze ƒe Dzidziɖedzi: Synaptic Plasticity kple Ŋkuɖodzinu ƒe Dɔwɔwɔ ƒe Dodoɖeŋgɔ
Esi peptide-nuawo ƒe taɖodzinue nye be yewoakpɔ susu ƒe dɔwɔwɔ ƒe toɖeɖe kple nusɔsrɔ̃-ŋkuɖodzinu ƒe gbɔdzɔgbɔdzɔ ta la, wowɔa dɔ to ahɔhɔ̃mekawo ƒe dɔwɔwɔ kple lãmenugbagbeviwo ƒe wɔwɔmewo dzi kpɔkpɔ me.
Synaptic ƒe ŋgɔyiyi to nootropic peptides dzi
Peptide aɖewo (le kpɔɖeŋu me, Sema) srɔ̃a lãmetsi si ɖea thyrotropin ɖa ƒe dɔwɔwɔ, si doa dopamine kple norepinephrine ƒe dodo ɖe ŋgɔ. Esia doa ŋusẽ synaptic plasticity le hippocampus me, si wɔnɛ be teƒe ƒe ŋkuɖoɖonudzi nyona ɖe edzi le Alzheimer ƒe dɔléle ƒe kpɔɖeŋuwo me. Dɔdaƒe ŋuti numekukuwo ɖee fia be woate ŋu ado susu ƒe dzesiwo kple nyatakakawo ŋuti dɔwɔwɔ kabakaba ɖe dzi.
Cholinergic system ƒe ɖoɖowɔwɔ
Peptide aɖewo siwo srɔ̃a cholinergic doa acetylcholine ƒe kaka ƒe dɔwɔwɔ ɖe ŋgɔ eye wònaa choline ƒe agbɔsɔsɔ le synaptic clefts me nyona ɖe edzi, si léa ŋutete ɖe asi be wòade nu susu ƒe dɔmawɔmawɔ nyuie kple dɔwɔwɔ vɔ megbe ƒe susu ƒe ɖiɖi me.
Anti-amyloid ƒe ƒuƒu:
Aβ-targeting sequences (le kpɔɖeŋu me, peptide ƒe akpa 176–191) xea mɔ na Aβ fibril ƒe ƒuƒoƒo, si ɖea ahɔhɔ̃mekawo ƒe aɖi ƒe kpeƒekpeƒewo ƒe wɔwɔ dzi kpɔtɔna eye wòhea Alzheimer ƒe dɔlélea ƒe dɔléle ƒe ŋgɔyiyi ɖe megbe, si wɔnɛ be wozua numekuku ƒe teƒe vevi aɖe na nudede eme kaba.
3. Seselelãme ƒe Ðoɖowɔwɔ: Ahɔhɔ̃mekawo ƒe Dadasɔ Kple Nuteɖeamedzi ƒe Ŋuɖoɖo Gbugbɔgawɔ
Peptide-nu siwo dea nu seselelãme ƒe kuxiwo abe dzimaɖitsitsi kple blanuiléle ene me to dɔwɔwɔ ɖe limbic system kple neuroendocrine axis dzi.
5-HT mɔ ƒe tɔtrɔ
Peptide aɖewo (le kpɔɖeŋu me, Sel), abe GABA_A xɔlawo ƒe tɔtrɔ nyuiwo ene, doa ŋusẽ γ-aminobutyric acid (GABA) ƒe mɔxexeɖedɔléle ƒe kaka, si ɖea dzimaɖitsitsi ƒe dzesiwo dzi kpɔtɔna kabakaba. Woƒe gɔmedzedze ƒe duƒuƒu kple dedienɔnɔ ƒe nɔnɔme wu benzodiazepine siwo wozãna tsã. Tachykinin receptor antagonist peptides na anhedonia le blanuiléle me nyona ɖe edzi to mɔxexe ɖe nusi nye P ƒe dodo nu me.
HPA axis ƒe ɖoɖowɔwɔ
Peptides abe oxytocin ene doa ŋusẽ amygdala ƒe prefrontal cortical regulation, si ɖea nuteɖeamedzi ƒe lãmetsi si nye cortisol ƒe agbɔsɔsɔ dzi kpɔtɔna. Esia nana seselelãme ƒe ŋkuɖoɖonudzi ƒe dɔwɔwɔ nyona ɖe edzi le hadome dzimaɖitsitsi kple nuteɖeamedzi megbe nuteɖeamedzi (PTSD) me.
Neuroplasticity dzadzraɖo
Peptide siwo wokpɔ tso BDNF me doa dendritic spine tsitsi ɖe ŋgɔ le hippocampal ahɔhɔ̃mekawo me, wogbugbɔa synaptic density si dzi ɖe kpɔtɔ to nuteɖeamedzi atraɖii me la ɖoa anyi eye wòdzraa seselelãme ƒe ɖoɖowɔwɔ ƒe dɔwɔwɔwo ɖo le xɔtuɖoɖo ƒe ɖoɖo nu.
4. Ahɔhɔ̃mekawo ƒe Abi Dzadzraɖo: Gbugbɔgadzɔ ƒe Ðoɖowo Kple Axonal Gbugbɔgatsi ƒe Dɔwɔwɔ
Le abi siwo womate ŋu atrɔ o abe aklã ƒe abixɔxɔ kple ahɔhɔ̃meka siwo le gota gome ene gome la, peptide-nuawo ɖua gbugbɔgadzɔ ƒe nuto sue si xea mɔ na wo dzi.
Axonal ƒe tsitsi dodo ɖe ŋgɔ
Peptide siwo srɔ̃a NGF naa TrkA xɔlawo wɔa dɔ, si wɔnɛ be ahɔhɔ̃mekawo ƒe axon didi. Le sciatic nerve injury models me la, wonaa axonal regrowth kabakaba eye wòna motor function ƒe hayahaya nyona ɖe edzi. Peptide siwo do ƒome kple chondroitinase (le kpɔɖeŋu me, Chonluten) gblẽa mɔxexeɖedɔlékui proteoglycans abe chondroitin sulfate ene, si ɖea abi ƒe mɔxenuwo ɖa le aklã ƒe abixɔxɔ megbe.
Schwann lãmenugbagbeviwo ƒe dɔwɔwɔ dzi kpɔkpɔ
Peptide siwo kpɔa dɔgboa ta (le kpɔɖeŋu me, BPC-157) doa Schwann lãmenugbagbeviwo ƒe dzidziɖedzi kple myelin ƒe wɔwɔ ɖe ŋgɔ, si wɔnɛ be lãmekawo ƒe ʋuʋu ƒe duƒuƒu nyona ɖe edzi le suklidɔ ƒe ahɔhɔ̃mekawo ƒe dɔléle si le gota gome eye wòɖea vevesese kple seselelãme ƒe dɔmawɔmawɔ nyuie dzi kpɔtɔna.
Stem cell ƒe ʋuʋu kple vovototodedeameme
Peptide siwo wokpɔ tso FGF-2 me nana ahɔhɔ̃meka siwo le lãmenugbagbeviwo me la ʋuna yia abixɔƒewo eye wotoa vovo zua ahɔhɔ̃meka siwo wɔa dɔ kple glial lãmenugbagbeviwo, si naa lãmenugbagbeviwo ƒe gɔmeɖoanyi na titina lãmekawo ƒe gbugbɔgadzɔ.
Nyanuwuwuw
Peptidenuwo zazã le ahɔhɔ̃mekawo kple susu ƒe lãmesẽ me de dzesi tɔtrɔ tso 'dzesiwo ƒe gbɔdzɔe' dzi yi 'ahɔhɔ̃mekawo ƒe gbugbɔgadzɔ' dzi le atikewɔwɔ ƒe kpɔɖeŋuwo me. To oxidative stress, synaptic dɔwɔwɔ, ahɔhɔ̃mekawo ƒe dɔdzẽ, kple gbugbɔgadzɔ ƒe mɔwo dzi ɖuɖu me la, nu siawo ɖea mɔnu vovovowo ƒe dɔwɔwɔ aduadu ƒe viɖewo fiana le ahɔhɔ̃mekawo takpɔkpɔ, susu ƒe dɔwɔwɔ nyuie, seselelãme ƒe ɖoɖowɔwɔ, kple abi ɖɔɖɔɖo me—vevietɔ woɖea ŋutete si womate ŋu aɖɔli o fiana le ahɔhɔ̃mekawo ƒe dɔmawɔmawɔ nyuie kple nuveviwɔame ɖɔɖɔɖo me.
NYATAKAKAWO KPLE NUSIWO WOTSƆ ƑE NYATAKAKA SIWO KAtã WOÐO LE NYATAKAKADZRAÐOƑE SIA ME LA KPLE NYATAKAKAWO kaka KPLEE NUFIAFIA ƑE TAÐOÐOWO KO.
Wotrɔ asi le atike siwo wona le nyatakakadzraɖoƒe sia ŋu na numekuku le vitro ɖeɖeko. Wowɔa numekuku le vitro (Latingbe me: *le ahuhɔ̃e me*, si gɔmee nye le ahuhɔ̃e me) le amegbetɔ ƒe ŋutilã godo. Atike siawo menye atikewo o, United States ƒe Nuɖuɖu Kple Atike Ŋuti Dɔwɔƒe (FDA) meda asi ɖe wo dzi o, eye mele be woazã wo atsɔ axe mɔ ɖe atikewɔwɔ, dɔléle, alo dɔléle aɖeke nu, adae, alo adae o. Se de se vevie be woatsɔ atike siawo ade amegbetɔ alo lãwo ƒe ŋutilã me le mɔ ɖesiaɖe nu.
